Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rank in Stocks #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Share Price
$2.69
Market Cap
$40.34M
Change (1 day)
-1.47%
Change (1 year)
-48.27%
Country
US
Trade Serina Therapeutics, Inc. (SER)

Category

Stock price history for Serina Therapeutics, Inc. (SER)
Highest end of day price: $2.72 on 2026-08-01

Lowest end of day price: $144.83 on 2018-11-01
Stock price history of Serina Therapeutics, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.36%
2025 -43.87%
2024 -59.83%
2023 -35.10%
2022 -9.36%
2021 -62.79%
2020 13.31%
2019 -58.69%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$541.84 37.40%
US
$1.03K 55.89%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$129.21 380.51%
US